<SEC-DOCUMENT>0000950170-24-111809-index.html : 20241002
<SEC-HEADER>0000950170-24-111809.hdr.sgml : 20241002
<ACCEPTANCE-DATETIME>20241002185013
ACCESSION NUMBER:		0000950170-24-111809
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20240930
FILED AS OF DATE:		20241002
DATE AS OF CHANGE:		20241002

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Bedrosian Camille L
		CENTRAL INDEX KEY:			0001326969
		ORGANIZATION NAME:           	

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-41199
		FILM NUMBER:		241349345

	MAIL ADDRESS:	
		STREET 1:		C/O ULTRAGENYX PHARMACEUTICAL INC.
		STREET 2:		60 LEVERONI COURT
		CITY:			NOVATO
		STATE:			CA
		ZIP:			94949

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Amylyx Pharmaceuticals, Inc.
		CENTRAL INDEX KEY:			0001658551
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				464600503
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		43 THORNDIKE STREET
		CITY:			CAMBRIDGE
		STATE:			MA
		ZIP:			02141
		BUSINESS PHONE:		617-683-0917

	MAIL ADDRESS:	
		STREET 1:		43 THORNDIKE STREET
		CITY:			CAMBRIDGE
		STATE:			MA
		ZIP:			02141
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>ownership.xml
<DESCRIPTION>4
<TEXT>
Document 1 - file: ownership.html

Document 1 - RAW XML: ownership.xml

</DOCUMENT>
</SEC-DOCUMENT>